Siteman Investment Program Research Development Awards (SIP RDAs)

The 2024 Cycle 2 Statements of Intent Window is Now CLOSED.
Full application deadline for all submitted SOIs is Monday, September 23 at 4pm CST.

2024 Cycle 2 SIP RDA Request for Applications (RFA) – Guidelines color-coded by category

The SIP RDA will fund research projects twice per year. Currently, there are seven mechanisms available:

  • CLINICAL TRIAL CATEGORY
    • New Clinical Trial Mechanism; up to $300,000 over 3 years
    • Existing Clinical Trial Mechanism; up to $100,000 over 2 years (updated amount)
    • Phase 0/1 Brain Tumor Center (BTC) Clinical Trial Mechanism; up to $150,000 over 3 years (updated amount)
  • PRE-R01 CATEGORY
    • The Pre-R01 Mechanism; up to $200,000 over 2 years (includes projects with Prevention and Control focus)
    • Pre-R01 Mechanism for University of Missouri-Columbia Collaboration; up to $200,000 over 2 years
  • TEAM SCIENCE CATEGORY
    • Team Science Mechanism; up to $800,000 over 2 years
  • COE SUPPLEMENT CATEGORY
    • COE Supplement Mechanism; up to $50,000 over 1 year (may request up to $100,000 directs with pre-approval as outlined in the RFA)

Complete information on each mechanism can be found in the Request for Applications (RFA) each cycle. A RFA will be announced twice per year on the following schedule:

GENERAL SIP DATE GUIDELINES* Cycle 2 2024
Current Cycle
 Cycle 1 2025
Next Cycle
Announcement: July 19, 2024
 January 2025
Statement of Intent deadline:
REQUIRED
 August 26, 2024
 March 2025
Full applications due:
via proposalCENTRAL		 Sept. 23, 2024
 April 2025
Anticipated decision notices: December 2024
 June 2025
Start dates: January 1, 2025
 July 1, 2025
*Dates may vary based on weekends, holidays, and other unforeseen circumstances.

Please consult the specific cycle’s RFA announcement for official deadlines.

2024 Cycle 2 Official Dates

Announcement: July 19, 2024
Statement of Intent (REQUIRED) deadline: August 26, 2024 at 4pm CST
Application deadline: September 23, 2024 at 4pm CST
Anticipated decision notice: December 15, 2024
Start date: January 1, 2025

2024 Cycle 2 Application Documents

SIP RDA Request for Applications (RFA) – Guidelines color-coded by category
SIP RDA Application Cover Sheet Form – (required – updated 07/2023)
SIP RDA Clinical Trial Category Budget Form – (required – updated 01/2024)

Success Rates

Success rates have been computed over the span of SIP RDA by mechanism and include applications that were scientifically reviewed. Success rates are determined by dividing the number of applications funded by the total number of applications reviewed. The current success rate for the Pre-R01 Category is 19%.

Re-submissions are welcome and encouraged every cycle. The success rate for re-submissions across all mechanisms is 29%.

Previous Awardees

For the full list of previous SIP RDA awardees, click HERE.

Contact

Contact Steve Baer at Siteman Cancer Center for more information or any questions, [email protected].